Late Breaking News
WASHINGTON — Despite dire warnings by VA officials, last month's 16-day government shutdown did not halt progress on eliminating VA's disability claims backlog.
FT. WORTH, TX — The first treatment for facial erythema in adults caused by rosacea has been approved by the Food and Drug Administration.
SUMMIT, NJ — The approved uses of Abraxane — paclitaxel protein-bound particles for injectable suspension, albumin-bound — have been expanded by the Food and Drug Administration to treat patients with metastatic pancreatic cancer in late stages.
DEERFIELD, IL — Brintellix (vortioxetine) has been approved by the Food and Drug Administration to treat adults with major depressive disorder (MDD).
HOUSTON — Should pay-for-performance be more widely used to incentivize VA clinicans to improve healthcare quality?
Opinion poll: Should pay-for-performance be used to improve healthcare quality at the VA? Please click here to participate in this month's U.S. Medicine readership poll.
WASHINGTON — In the wake of accusations that veterans are over-prescribed powerful painkillers, a House of Representatives subcommittee chairman called on VA to adopt more effective pain management protocols.
FORT LAUDERDALE, FL — The newly released National Research Action Plan has created a “common roadmap” for federal agencies to tackle mental health research to include PTSD, TBI and suicide, DoD and VA officials said recently.
MEMPHIS, TN — Proteinuria-lowering interventions in patients with advanced chronic kidney disease (CKD) should be implemented cautiously, considering the potential for adverse outcomes, according to a new study led by researchers from the Memphis, TN, VAMC.
MINNEAPOLIS — A newly-developed risk model can be used to predict the occurrence of end-stage renal disease (ESRD) and appropriately prepare for renal replacement therapy in veterans with advanced chronic kidney disease, according to a new study.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List